Army Picks Battelle to Develop Vaccines for Biological, Chemical Threats Under $59M Contract

Health research managementBattelle has received a potential five-year, $59 million contract from the U.S. Army to conduct research and develop therapeutics and vaccines for chemical and biological threats.

The Army’s joint program executive office for chemical and biological defense awarded the contract through the General Services Administration‘s One Acquisition Solution for Integrated Services contract vehicle, Battelle said Monday.

Battelle will work to develop vaccines for filovirus, botulinum, plague, equine encephalitis and other viruses that could be potentially used as biological weapons.

Contract work also covers the development of medical countermeasures against poisonous toxins and nerve agents used in chemical warfare.

You may also be interested in...

SBIRS GEO-5 Satellite Lockheed Martin

Lockheed-Made SBIRS GEO-5 Satellite Set for Launch Next Year

Lockheed Martin has announced the launch readiness of an upcoming military space satellite designed to provide missile warning via infrared technology. The company said Wednesday its fifth Space-Based Infrared System Geosynchronous Earth Orbit satellite or SBIRS GEO-5 is set for flight in 2021, following the satellite's completion in October this year.


Parsons Announces New Products for Cloud Native Streaming

Parsons has unveiled a new series of cloud products designed to help government and commercial customers process large amounts of data while ensuring lesser infrastructure costs. The company said Wednesday it will offer cloud native stream platforms to deliver the scalability needed to maximize cloud resources.


Bitglass Gets FedRAMP OK for Secure Cloud Access Offering

Bitglass has earned a certification under the Federal Risk and Authorization Management Program for a platform developed to protect any interaction between devices, applications, on-premises resources, infrastructure and web destinations.